Theranostic Contact Lens for Ocular Cystinosis Utilizing Gold Nanoparticles

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Ophthalmology

Background:

• Ocular cystinosis involves cystine crystal accumulation, damaging the eyes and requiring frequent treatment and monitoring.
• Current treatments like cysteamine eye drops have low bioavailability and potential toxicity, necessitating precise dosing.
• Existing cystine level assessment is subjective (slit-lamp examination), causing patient discomfort and frequent clinic visits.

Purpose of the Study:

• To develop a theranostic contact lens for simultaneous therapy and diagnosis of ocular cystinosis.
• To utilize gold nanoparticles (GNPs) for cystine detection and potential therapeutic delivery.
• To create an objective, patient-friendly method for monitoring cystine levels.

Main Methods:

• Confirmed binding interactions between gold nanoparticles (GNPs) and cystine in solution.
• Performed thermodynamic analysis to understand the bonding forces.
• Developed and tested a GNP-loaded contact lens (GNP-CL) for cystine detection.

Main Results:

• GNP-CL showed distinct color changes (red to blue) upon exposure to varying cystine concentrations, enabling quantitative monitoring.
• Demonstrated treatment efficacy by confirming a reduction in cystine concentration after reaction.
• Validated the potential for objective, self-monitoring of cystine levels without specialized equipment.

Conclusions:

• The theranostic GNP-CL platform offers a promising approach for improved ocular cystinosis management.
• This innovation can reduce dependence on frequent cysteamine administration.
• Provides an objective, accessible self-monitoring tool for patients.